By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


Company News
Agios (AGIO)' Anemia Drug Data Hits Mark in Mid-Stage Study 6/13/2016 7:28:20 AM
Agios (AGIO) Reports Initial Data From Phase I Study Of AG-519 In Healthy Volunteers 6/9/2016 1:35:43 PM
Agios (AGIO), Celgene (CELG) Hammer Out $1 Billion+ Metabolic Immuno-Oncology Deal 5/18/2016 5:53:11 AM
10 Massachusetts Biotechs Devoting the Most Cash to R&D 5/5/2016 6:29:13 AM
Agios (AGIO) Appoints Steve Hoerter As Chief Commercial Officer 2/8/2016 10:28:28 AM
Agios (AGIO) To Present At The 34th Annual J.P. Morgan Healthcare Conference On Monday, January 11 1/4/2016 7:15:21 AM
Agios (AGIO) Announces Data From Ongoing Phase I Trial Of AG-120 Showing Durable Responses In Patients With Advanced Hematologic Malignancies 12/7/2015 7:38:20 AM
Agios (AGIO) Announces Data From Dose-Escalation Phase I Study Of AG-120 In Patients With IDH1 Mutant Positive Advanced Solid Tumors 11/9/2015 7:30:55 AM
Agios (AGIO) Reports Third Quarter 2015 Financial Results 11/5/2015 10:22:45 AM
Agios (AGIO) To Present New Data From Lead Programs At The 2015 American Society of Hematology Annual Meeting 11/5/2015 8:27:38 AM